Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy

NCT05019365 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT05019365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05019365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
Lead sponsor
University of Glasgow
Phase
Observational
Overall status
Unknown status
Start date
March 15, 2021
Completion date
November 25, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, her2-positive breast cancer